IPO watch

Endocyte, Pacira prepare to be early 2011 biotech IPOs

After filling in offering details in their S-1s last week, oncology company Endocyte Inc. and specialty pain play Pacira Pharmaceuticals Inc. may be among the

Read the full 250 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE